What is the Scaleup Europe Fund's target size and investment focus, according to the news?

The Scaleup Europe Fund is a pan-European growth fund with a target size of 5 billion euros and a hard cap of 6–7 billion euros, focused on supporting technology companies through growth, late-stage growth, and pre-IPO phases across three themes: digital and intelligent systems, physical systems, and human and planetary health.

Who are the founding investors of the Scaleup Europe Fund, and what role does Novo Holdings play?

The founding investors include the European Commission, Novo Holdings (which committed 500 million euros as a founding investor), EIFO (Export and Investment Fund of Denmark), CriteriaCaixa, Santander, and Allianz; Novo Holdings, the controlling shareholder of Novo Nordisk, serves as a key institutional anchor and catalyst for the fund’s launch.

Novo Holdings Commits 500 Million Euros to New European Tech Growth Fund

Jun 4, 2026

Novo Holdings, controlling obesity drugmaker Novo Nordisk, invested 500 million euros in the pan-European Scaleup Europe Fund. The fund targets technology companies in digital, physical, and health sectors, with investments starting in autumn 2026.

reuters

2026-06-04

Novo Holdings Commits 500 Million Euros to New European Tech Growth Fund

2026-08-12

Novo Holdings Fund Deems US Renewables 'Much More Attractive'

Novo Holdings Commits 500 Million Euros to New European Tech Growth Fund

FAQ